Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-κB pathway and downstream enzymes involved in prostaglandin biosynthesis

Journal of Neurochemistry

Volumn 98, Issue 3, 2006, Pages 801-811

  Choi, Sang Ho ^a   Langenbach, Robert ^b   Bosetti, Francesca ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cyclooxygenase; NF B; PGE2; Phospholipase A2; Prostaglandin E synthase

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; MESSENGER RNA; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROTEIN P50; SYNAPTOTAGMIN;

ARTICLE; BIOSYNTHESIS; BRAIN FUNCTION; DOWNSTREAM PROCESSING; ENZYME ACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; WILD TYPE;

ANIMALS; BRAIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-KAPPA B; PROSTAGLANDINS; SIGNAL TRANSDUCTION;

EID: 33745883790     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03926.x     Document Type: Article

References (55)

1. Adams J., Collaco-Moraes Y. and de Belleroche J. (1996) Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation. J. Neurochem. 66, 6-13.
2. 2 in CSF from ALS patients. Neurology 58, 1277-1279.
3. Andreani M., Olivier J. L., Berenbaum F., Raymondjean M. and Bereziat G. (2000) Transcriptional regulation of inflammatory secreted phospholipases A (2). Biochim. Biophys. Acta 1488, 149-158.
4. Ayoub S. S., Botting R. M., Goorha S., Colville-Nash P. R., Willoughby D. A. and Ballou L. R. (2004) Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. Proc. Natl Acad. Sci. USA 101, 11 165-11 169.
5. 2. J. Neurochem. 91, 1389-1397.
6. 2 knockout mouse. J. Neurochem. 87, 1471-1477.
7. Chen Z. J. (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol. 7, 758-765.
8. 2. J. Lipid Med. Cell Signal 12, 83-117.
9. Cok S. J. and Morrison A. R. (2001) The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J. Biol. Chem. 276, 23 179-23 185.
10. Di Rosa M., Ialenti A., Ianaro A. and Sautebin L. (1996) Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukot Essent Fatty Acids 54, 229-238.
11. Dixon D. A., Kaplan C. D., McIntyre T. M., Zimmerman G. A. and Prescott S. M. (2000) Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J. Biol. Chem. 275, 11 750-11 757.
12. Faour W. H., He Y., He Q. W., de Ladurantaye M., Quintero M., Mancini A. and Di Battista J. A. (2001) Prostaglandin E (2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. J. Biol. Chem. 276, 31 720-31 731.
13. Fujimoto Y., Uno E. and Sakuma S. (2004) Effects of reactive oxygen and nitrogen species on cyclooxygenase-1 and -2 activities. Prostaglandins Leukot Essent Fatty Acids 71, 335-340.
14. Griffin D. E., Wesselingh S. L. and McArthur J. C. (1994) Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35, 592-597.
15. 2 is increased in amyotrophic lateral sclerosis patients. Acta Neurol. Scand. 108, 125-129.
16. 2 as a mediator of fever: synthesis and catabolism. Front Biosci. 9, 1977-1993.
17. Jakobsson P. J., Thoren S., Morgenstern R. and Samuelsson B. (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl Acad. Sci. USA 96, 7220-7225.
18. Kanekura T., Goorha S., Kirtikara K. and Ballou L. R. (2002) The involvement of NF-kappaB in the constitutive overexpression of cyclooxygenase-2 in cyclooxygenase-1 null cells. Biochim. Biophys. Acta 1542, 14-22.
19. Kaufmann W. E., Andreasson K. I., Isakson P. C. and Worley P. F. (1997) Cyclooxygenases and the central nervous system. Prostaglandins 54, 601-624.
20. 2 biosynthesis in cyclooxygenase 1 or 2 null cells. J. Exp Med. 187, 517-523.
21. 2 enzymes. Prostaglandins Other Lipid Med. 68-69, 3-58.
22. Langenbach R., Morham S. G., Tiano H. F., Loftin C. D., Ghanayem B. I., Chulada P. C., Mahler J. F., Lee C. A., Goulding E. H., Kluckman K. D., Kim H. S. and Smithies O. (1995) Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83, 483-492.
23. 2. J. Biol. Chem. 272, 16 709-16 712.
24. Li S., Wang Y., Matsumura K., Ballou L. R., Morham S. G. and Blatteis C. M. (1999) The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2 (-/-), but not in cyclooxygenase-1 (-/-) mice. Brain Res. 825, 86-94.
25. Lindstrom T. and Bennett P. (2004) Transcriptional regulation of genes for enzymes of the prostaglandin biosynthetic pathway. Prostaglandins Leukot Essent Fatty Acids 70, 115-135.
26. Livak K. J. and Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T) Method. Methods 25, 402-408.
27. Meffert M. K. and Baltimore D. (2005) Physiological functions for brain NF-kappaB. Trends Neurosci. 28, 37-43.
28. Minghetti L. (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol Exp Neurol. 63, 901-910.
29. 2 levels in patients with probable AD. Neurology 53, 1495-1498.
30. 2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and - 2. J. Biol. Chem. 278, 37 937-37 947.
31. Murakami M., Nakatani Y., Tanioka T. and Kudo I. (2002) Prostaglandin E synthase. Prostaglandins Other Lipid Med. 68-69, 383-399.
32. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32 783-32 792.
33. Narumiya S., Sugimoto Y. and Ushikubi F. (1999) Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79, 1193-1226.
34. Nishino S., Ueno R., Ohishi K., Sakai T. and Hayaishi O. (1989) Salivary prostaglandin concentrations: possible state indicators for major depression. Am. J. Psychiatry 146, 365-368.
35. Parente L. and Perretti M. (2003) Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem. Pharmacol. 65, 153-159.
36. 2 synthesis and lipid peroxidation after in vivo activation of N-methyl-D-aspartate receptors in rat hippocampus. J. Neurochem. 93, 1561-1567.
37. Poligone B. and Baldwin A. S. (2001) Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins. J. Biol. Chem. 276, 38 658-38 664.
38. Powell W. S. (1985) Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenases. Anal Biochem. 148, 59-69.
39. Rao J. S., Langenbach R. and Bosetti F. (2005) Down-regulation of brain nuclear factor-kappa B pathway in the cyclooxygenase-2 knockout mouse. Brain Res. Mol Brain Res. 139, 217-224.
40. Rapoport S. I. and Bosetti F. (2002) Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch. General Psychiatry 59, 592-596.
41. Salvemini D. (1997) Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci. 53, 576-582.
42. Schwab J. M. and Schluesener H. J. (2003) Cyclooxygenases and central nervous system inflammation: conceptual neglect of cyclooxygenase 1. Arch. Neurol. 60, 630-632.
43. Smith W. L., DeWitt D. L. and Garavito R. M. (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145-182.
44. Sublette M. E., Russ M. J. and Smith G. S. (2004) Evidence for a role of the arachidonic acid cascade in affective disorders: a review. Bipolar Disord 6, 95-105.
45. Tamura M., Sebastian S., Yang S., Gurates B., Fang Z. and Bulun S. E. (2002) Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. J. Clin. Endocrinol. Metab 87, 3263-3273.
46. Tanabe T. and Tohnai N. (2002) Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Med. 68-69, 95-114.
47. Tanikawa N., Ohmiya Y., Ohkubo H., Hashimoto K., Kangawa K., Kojima M., Ito S. and Watanabe K. (2002) Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem. Biophys. Res. Commun 291, 884-889.
48. 2 biosynthesis. J. Biol. Chem. 275, 32 775-32 782.
49. 2). Biochim. Biophys. Acta 1217, 345-347.
50. Tsuboi K., Sugimoto Y. and Ichikawa A. (2002) Prostanoid receptor subtypes. Prostaglandins Other Lipid Med. 68-69, 535-556.
51. 2 synthases and cyclooxygenases in the brain. Am. J. Physiol. Regul Integr Comp Physiol. 287, R1155-R1163.
52. Vichai V., Suyarnsesthakorn C., Pittayakhajonwut D., Sriklung K. and Kirtikara K. (2005) Positive feedback regulation of COX-2 expression by prostaglandin metabolites. Inflamm Res. 54, 163-172.
53. Wang L. H. and Kulmacz R. J. (2002) Thromboxane synthase: structure and function of protein and gene. Prostaglandins Other Lipid Med. 68-69, 409-422.
54. Yamagata K., Andreasson K. I., Kaufmann W. E., Barnes C. A. and Worley P. F. (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11, 371-386.
55. Zhang J., Goorha S., Raghow R. and Ballou L. R. (2002) The tissue-specific, compensatory expression of cyclooxygenase-1 and -2 in transgenic mice. Prostaglandins Other Lipid Med. 67, 121-135.